SPİNK1's value in diagnosis of hepatocellular carcinoma
2016
0 views
0 downloads
Advisor: Prof. Dr. Neşe Karadağ
Abstract (EN)
HCC(hepatocellular carcinoma) is the most common 6th cancer seen in all around the world. Dysplastic lesions are a source of diagnostic difficulty in HCC differential. CC is 2nd most commonly seen primary liver cancer. In this study, Spink1(TATI) is used immunochemically for patients who were diagnosed with HCC(69), CC(15), LGDF(31) and HGDF(6) at Inonu University Pathology Department between 2010 and 2015. There is no significant statistical difference seen between HCC - CC and HCC - HGDN in terms of staining rate(p=0.394, p=1). It is concluded that Spink1 does not help with the differential diagnosis of HCC, CC and HGDN. It is shown that Spink1 stain makes a significant distinction(p=0.031) of HCC with LGDN(p=0.0001) and normal liver tissue(p=0.0001), and also with LGDN and HGDN. Key words: Hepatocellular carcinoma, Cholangiocarcinoma, High grade dysplastic focus, Low grade dysplastic focus, Spink1
Author
Dr. Buket Akyüz Erdoğan
How to Cite
Buket Akyüz Erdoğan (Medical Specialty Thesis). SPİNK1's value in diagnosis of hepatocellular carcinoma, 2016, İnönü University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from İnönü University
- Knowledge, opinions and applications of pediatric nurses towards therapeutic games(2017)
- The effects of systemic pistacia eurycarpa yalt administration on alveolar bone loss and oxidative stress in rats with experimental periodontitis(2021)
- The effect of motivational interviews for primiparous pregnant women with low normal birth belief on medical and natural birth belief(2022)
- Retrospective investigation of genetic etiology in pediatric epilepsy patients based on targeted next generation sequence analysis datas(2022)
- The commentary methodology in the commentary on al-Fath al-Mubyn bi-Sharh al-Arba'eyn by Ibn Hajar al-Haytamy(2022)
- Comparison of serum BDNF, S100B levels of patients with bipolar disorder in manic and remission periods with healthy volunteers and evaluation of results with neuropsychological tests(2022)
